Bharat Rasayan Ltd

Bharat Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bharat Rasayan Ltd

₹ 10,012 0.27%
23 Jun 4:01 p.m.
bharatgroup.co.in BSE: 590021 NSE: BHARATRAS
About

Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]

Key Points

Product Portfolio
The company has a leading market position in many technical and intermediate products, including Lambda Cyhalothrin Technical, Metaphenoxy Benzaldehyde, Metribuzine Technical, Thiamethoxam (Insecticides), Fipronil (Insecticides), etc. It has also added new products like Fluxametamide, Tolfenpyrad Technical, Diuron Technical, etc. Top 10 products account for 66% of total sales. [1]

Website BSE NSE
  • Market Cap ₹ 4,167 Cr.
  • Current Price ₹ 10,012
  • High / Low ₹ 14,284 / 8,798
  • Stock P/E 33.3
  • Book Value ₹ 2,663
  • Dividend Yield 0.01 %
  • ROCE 15.4 %
  • ROE 12.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of -0.67% over past five years.
  • Company has a low return on equity of 12.0% over last 3 years.
  • Dividend payout has been low at 0.58% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
445 327 292 309 306 239 263 233 310 282 328 256 307
359 275 256 258 247 234 248 205 240 244 273 215 266
Operating Profit 86 52 36 52 59 6 15 28 69 38 55 42 40
OPM % 19% 16% 12% 17% 19% 2% 6% 12% 22% 14% 17% 16% 13%
7 8 3 6 -3 2 4 4 11 6 7 7 6
Interest 3 2 1 2 1 0 1 1 1 1 1 1 1
Depreciation 7 6 7 7 6 6 6 7 6 6 6 7 7
Profit before tax 83 52 31 49 48 1 12 24 73 37 54 41 38
Tax % 23% 25% 26% 26% 32% 46% 34% 27% 23% 27% 25% 27% 25%
65 39 23 37 33 1 8 17 56 27 40 30 28
EPS in Rs 155.32 92.92 55.45 88.01 78.48 1.76 18.51 41.59 134.55 64.50 96.62 71.45 68.49
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
360 438 451 618 792 989 1,213 1,091 1,301 1,234 1,044 1,173
296 355 370 508 634 802 983 851 1,049 1,037 926 998
Operating Profit 64 82 81 111 159 188 230 240 252 197 118 175
OPM % 18% 19% 18% 18% 20% 19% 19% 22% 19% 16% 11% 15%
1 1 1 2 4 1 14 6 16 15 21 26
Interest 17 18 13 12 12 16 16 4 7 6 3 5
Depreciation 18 18 17 16 16 17 22 26 25 26 26 27
Profit before tax 30 48 52 84 135 155 205 216 235 180 109 169
Tax % 33% 34% 34% 35% 27% 28% 23% 24% 25% 27% 25% 26%
20 32 34 55 98 112 158 164 177 131 82 125
EPS in Rs 47.43 74.73 79.74 128.35 231.39 262.48 371.03 387.11 426.27 314.85 196.40 301.06
Dividend Payout % 2% 2% 2% 1% 1% 1% 0% 0% 0% 0% 1% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: -1%
3 Years: -3%
TTM: 12%
Compounded Profit Growth
10 Years: 15%
5 Years: -5%
3 Years: -11%
TTM: 56%
Stock Price CAGR
10 Years: 27%
5 Years: 8%
3 Years: -3%
1 Year: -16%
Return on Equity
10 Years: 20%
5 Years: 16%
3 Years: 12%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 78 109 142 196 294 405 560 724 768 897 978 1,102
143 140 111 115 128 247 94 58 174 28 80 85
82 82 69 54 77 100 94 122 142 152 129 193
Total Liabilities 307 335 326 369 504 756 752 908 1,087 1,082 1,192 1,385
142 137 136 131 148 150 203 191 228 225 230 230
CWIP 1 2 1 1 7 35 18 18 11 11 6 15
Investments 0 30 20 0 0 0 9 151 45 75 137 275
164 167 169 237 349 570 522 549 803 771 818 865
Total Assets 307 335 326 369 504 756 752 908 1,087 1,082 1,192 1,385

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
29 60 47 16 29 -52 263 170 -65 213 41 172
-25 -41 -5 8 -31 -46 -53 -149 64 -43 -76 -157
-3 -19 -43 -24 2 102 -169 -40 -25 -152 49 -1
Net Cash Flow 1 -0 -1 -0 0 4 40 -19 -26 18 14 14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 61 66 71 71 102 103 75 99 130 96 138 130
Inventory Days 105 73 71 75 66 112 70 90 120 141 135 136
Days Payable 58 48 32 17 25 24 17 33 30 33 37 67
Cash Conversion Cycle 108 91 110 129 143 191 128 156 221 204 236 200
Working Capital Days 86 75 86 110 127 173 116 134 185 173 227 268
ROCE % 22% 27% 25% 34% 39% 32% 34% 31% 28% 20% 11% 15%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.00% 0.53% 0.39% 0.34% 0.35% 0.35% 0.34% 0.34% 0.35% 0.46% 0.45% 0.49%
2.89% 2.57% 2.60% 2.57% 2.57% 2.57% 2.57% 2.57% 2.59% 2.64% 2.60% 2.75%
22.11% 21.91% 22.02% 22.10% 22.09% 22.09% 22.09% 22.09% 22.07% 21.90% 21.96% 21.77%
No. of Shareholders 17,38416,37517,30417,23416,36116,05915,39814,66715,15615,88915,85715,036

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings